Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy.

Lachmann N, Brennig S, Phaltane R, Flasshove M, Dilloo D, Moritz T

Open source

DOI
10.1593/neo.121954
Published
2013 Mar
Container
Neoplasia (New York, N.Y.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1593/neo.121954,
  title = {Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy.},
  author = {Lachmann N and Brennig S and Phaltane R and Flasshove M and Dilloo D and Moritz T},
  year = {2013},
  journal = {Neoplasia (New York, N.Y.)},
  doi = {10.1593/neo.121954},
  url = {https://doi.org/10.1593/neo.121954}
}

RIS

TY  - JOUR
TI  - Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy.
AU  - Lachmann N
AU  - Brennig S
AU  - Phaltane R
AU  - Flasshove M
AU  - Dilloo D
AU  - Moritz T
PY  - 2013
JO  - Neoplasia (New York, N.Y.)
DO  - 10.1593/neo.121954
UR  - https://doi.org/10.1593/neo.121954
ER  - 

APA

N, L., S, B., R, P., M, F., D, D., & T, M. (2013). Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy.. Neoplasia (New York, N.Y.). https://doi.org/10.1593/neo.121954

Source records